Atlas Trials

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Clinical trial NCT04447716 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04447716
Sponsor
Thomas Jefferson University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin LymphomaRecurrent Marginal Zone LymphomaRefractory B-Cell Non-Hodgkin LymphomaRefractory Follicular LymphomaRefractory Indolent Adult Non-Hodgkin LymphomaRefractory Marginal Zone Lymphoma
Start date
2020-10-16
Primary completion
2024-05-16
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.